2020, Number 2
Nasal neurostimulation for the treatment of dry eye. A new option
Manteiga RMB, Collazo MY, Galiano LM
Language: Spanish
References: 6
Page: 1-6
PDF size: 242.75 Kb.
ABSTRACT
The nasolacrimal reflex upregulates tear production after chemical or mechanical stimulation of the nasal mucosa .The nasolacrimal reflex arc begins in the sensory nerves that line the nasal cavity (the afferent arm) and ends with the parasympathetic innervation of the main target tissues that contribute to the lacrimal production (the efferent arm). An intranasal lacrimal neurostimulator has been developed to induce normal tear production by stimulating the nasolacrimal reflex. The TrueTear ™ intranasal lacrimal neurostimulator (Allergan, Parkway Parsippany, NJ, USA) was recently approved by the FDA with an approved indication to provide a temporary increase in tear production during neurostimulation in adult patients. A series of additional studies are ongoing, and the results are awaiting publication. This device constitutes a new tool for the treatment of dry eye pathology that affects more than 15% of the world population.REFERENCES